Solid Biosciences (SLDB) EPS (Weighted Average and Diluted) (2020 - 2024)
Historic EPS (Weighted Average and Diluted) for Solid Biosciences (SLDB) over the last 4 years, with Q4 2024 value amounting to -$1.02.
- Solid Biosciences' EPS (Weighted Average and Diluted) fell 200.0% to -$1.02 in Q4 2024 from the same period last year, while for Dec 2024 it was -$3.06, marking a year-over-year increase of 3677.69%. This contributed to the annual value of -$3.06 for FY2024, which is 3664.6% up from last year.
- According to the latest figures from Q4 2024, Solid Biosciences' EPS (Weighted Average and Diluted) is -$1.02, which was down 200.0% from -$0.79 recorded in Q3 2024.
- Solid Biosciences' 5-year EPS (Weighted Average and Diluted) high stood at -$0.61 for Q2 2024, and its period low was -$6.17 during Q4 2020.
- Over the past 4 years, Solid Biosciences' median EPS (Weighted Average and Diluted) value was -$1.04 (recorded in 2023), while the average stood at -$1.73.
- Within the past 5 years, the most significant YoY rise in Solid Biosciences' EPS (Weighted Average and Diluted) was 6246.25% (2023), while the steepest drop was 4705.88% (2023).
- Quarter analysis of 4 years shows Solid Biosciences' EPS (Weighted Average and Diluted) stood at -$6.17 in 2020, then soared by 88.98% to -$0.68 in 2022, then crashed by 47.06% to -$1.0 in 2023, then decreased by 2.0% to -$1.02 in 2024.
- Its EPS (Weighted Average and Diluted) was -$1.02 in Q4 2024, compared to -$0.79 in Q3 2024 and -$0.61 in Q2 2024.